Indication
Epithelial ovarian cancer
Epithelial ovarian cancer is a malignant neoplasm that develops from the surface epithelium of the ovaries or, frequently, from the epithelial lining of the fallopian tubes or peritoneum. Read more about Epithelial ovarian cancer
125 drugs 66 manufacturers
Drugs that treat it
Common Epithelial ovarian cancer therapies.
DOXORUBICIN, PEG-LIPOSOMAL (doxorubicin HCl pegylated liposomal)
MVASI (bevacizumab-awwb)
PARAPLATIN (carboplatin)
ZIRABEV (bevacizumab-bvzr)
ALYMSYS (bevacizumab-maly)
VEGZELMA (bevacizumab-adcd)
HYCAMTIN (topotecan HCl)
CAELYX (doxorubicin HCl pegylated liposomal)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEpithelial ovarian cancer is a malignant neoplasm that develops from the surface epithelium of the ovaries or, frequently, from the epithelial lining of the fallopian tubes or peritoneum.
Affecting the female reproductive system, it represents approximately 90% of all ovarian cancer diagnoses and predominantly occurs in postmenopausal women.
The malignancy encompasses diverse histologic subtypes—most notably high-grade serous, endometrioid, clear cell, and mucinous carcinomas—frequently characterized by genomic alterations such as *TP53* mutations and homologous recombination deficiencies.
Because early stages produce vague, non-specific gastrointestinal or abdominal symptoms, the disease is typically diagnosed at an advanced stage characterized by extensive peritoneal dissemination and ascites.
- cancer.gov
Epithelial ovarian cancer is a malignant neoplasm that develops from the surface epithelium of the ovaries or, frequently, from the epithelial lining of the fallopian tubes or peritoneum
- nih.gov
Epithelial ovarian cancer is a malignant neoplasm that develops from the surface epithelium of the ovaries or, frequently, from the epithelial lining of the fallopian tubes or peritoneum
- nih.gov
Affecting the female reproductive system, it represents approximately 90% of all ovarian cancer diagnoses and predominantly occurs in postmenopausal women
- nih.gov
Affecting the female reproductive system, it represents approximately 90% of all ovarian cancer diagnoses and predominantly occurs in postmenopausal women The malignancy encompasses diverse histologic subtypes—most notably high-grade serous, endometrioid, clear cell, and mucinous carcinomas—frequently characterized by genomic alterations such as *TP53* mutations and homologous recombination deficiencies
- nih.gov
The malignancy encompasses diverse histologic subtypes—most notably high-grade serous, endometrioid, clear cell, and mucinous carcinomas—frequently characterized by genomic alterations such as *TP53* mutations and homologous recombination deficiencies
- nih.gov
Because early stages produce vague, non-specific gastrointestinal or abdominal symptoms, the disease is typically diagnosed at an advanced stage characterized by extensive peritoneal dissemination and ascites
- clevelandclinic.org
Because early stages produce vague, non-specific gastrointestinal or abdominal symptoms, the disease is typically diagnosed at an advanced stage characterized by extensive peritoneal dissemination and ascites
Personalize your experience
Follow Epithelial ovarian cancer and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.